The Iodinated contrast media in interventional X-ray market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 5.3% in the forecast period of 2020 to 2027 and expected to reach USD 1,408.81 million by 2027 from USD 941.26 million in 2019. High volumes of interventional and cardiac catheterization procedures and advancement in interventional radiology diagnostics are the major drivers for the growth of the market.
North America Iodinated Contrast Media in Interventional X-Ray Market Scope and Market Size: -
Based on agent type, iodinated contrast media in interventional X-ray market is segmented into ionic and non-ionic. Non-ionic segment is dominating the market due to its characteristics such as low osmolarity and low side effects.
Based on indication, iodinated contrast media in interventional X-ray market is segmented into cardiology, oncology, urology, general surgery and neurology. Cardiology segment is dominating the market due to high penetration of iodinated contrast agents in interventional cardiovascular diagnostics and growing popularity of non-ionic stable iodinated agents for improved diagnosis.
Based on end user, the market is segmented into hospital, specialty clinics, diagnostic centers, ambulatory surgical centers, research academic institutes. Hospital segment is dominating the market throughout the forecast period. Though, Hospital and specialty clinics capture almost three forth revenue share because the high patient volumes and high test demand.
Iodinated Contrast Media in Interventional X-Ray Market Country Level Analysis: -
U.S. is growing with a highest growth rate due to the increased number of cardiovascular CT procedure and high adoption of contrast agent in diagnostic testing for chronic diseases such as cardiac disorders, stroke, chronic lung disease and many others. Moreover, availability of well-equipped healthcare facilities and presence of reimbursement will also increase the demand for the iodinated contrast media in interventional X-ray during the forecast period.
Competitive Landscape and Iodinated Contrast Media in Interventional X-Ray : -
The major players covered in the report are Bayer AG, Iso-Tex Diagnostics, Inc., Bracco Diagnostic Inc., Novalek Pharmaceuticals Pvt. Ltd., iMAX, Taejoon Pharm, Unijules Life Sciences Ltd, General Electric, Guerbet LLC, J.B.Chemicals Pharmaceuticals Ltd among others players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
MAJOR TOC OF THE REPORT: -
- Chapter One: Introduction
- Chapter Two: Market Analysis and Insights
- Chapter Three: Market Dynamics
- Chapter Four: Market Scope
- Chapter Five: Market Regional Insights
- Chapter Six: Competitive Landscape System Market
Browse Related Reports: -
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Data Bridge Market Research